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Abstract
Introduction: The mechanisms underlying the strong association between percentage dense area on a
mammogram and the risk of breast cancer are unknown. We investigated separately the absolute dense area and
the absolute nondense area on mammograms in relation to breast cancer risk.
Methods: We conducted a nested case-control study on prediagnostic mammographic density measurements and
risk of breast cancer in the Nurses’ Health Study and the Nurses’ Health Study II. Premenopausal mammograms
were available from 464 cases and 998 controls, and postmenopausal mammograms were available from 960 cases
and 1,662 controls. We used a computer-assisted thresholding technique to measure mammographic density, and
we used unconditional logistic regression to calculate OR and 95% CI data.
Results: Higher absolute dense area was associated with a greater risk of breast cancer among premenopausal
women (ORtertile 3 vs 1 = 2.01, 95% CI = 1.45 to 2.77) and among postmenopausal women (ORquintile 5 vs 1 = 2.19,
95% CI = 1.65 to 2.89). However, increasing absolute nondense area was associated with a decreased risk of breast
cancer among premenopausal women (ORtertile 3 vs 1 = 0.51, 95% CI = 0.36 to 0.72) and among postmenopausal
women (ORquintile 5 vs 1 = 0.46, 95% CI = 0.34 to 0.62). These associations changed minimally when we included
both absolute dense area and absolute nondense area in the same statistical model. As expected, the percentage
dense area was the strongest risk factor for breast cancer in both groups.
Conclusions: Our results indicate that absolute dense area is independently and positively associated with breast
cancer risk, whereas absolute nondense area is independently and inversely associated with breast cancer risk.
Since adipose tissue is radiographically nondense, these results suggest that adipose breast tissue may have a
protective role in breast carcinogenesis.
Introduction
Mammographic density is one of the strongest predic-
tors of breast cancer risk. Breast epithelium and stroma
are radiographically dense and appear light on a mam-
m o g r a m ,w h e r e a sa d i p o s et i s s u ei sn o n d e n s ea n d
appears dark. Women with more than 75% of the total
area on a mammogram occupied by dense area have a
four- to sixfold greater risk of breast cancer compared
to women with little or no dense area on a mammo-
gram [1,2]. Although percentage dense area is the most
commonly used measurement of mammographic
density, absolute dense area is also associated with
breast cancer risk. Most studies that have investigated
both absolute and percentage dense area in relation to
breast cancer risk have reported similar or stronger
associations with percentage dense area [1,3-9].
The biological mechanisms underlying the association
between mammographic density and breast cancer risk
are unclear. It is plausible that mammographic density
is related to breast cancer risk because it reflects the
total amount of epithelium and stroma in the breasts
[10]. The association between absolute dense area and
breast cancer risk supports this view, since the dense
area on a mammogram is a measure of mammary tissue.
Percentage dense area, however, appears to be a better
predictor of breast cancer risk. A possible explanation of
this paradox is that the nondense area on a
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centage dense area, is inversely related to breast cancer
risk.
In this study, we separately investigated absolute dense
area, absolute nondense area and percentage dense area
in relation to breast cancer risk. The aim of the study
was to better understand the aspects of the association
between mammographic density and risk of breast can-
cer. Ap r i o r iw ee x p e c t e dt h e r et ob eap o s i t i v ea s s o c i a -
tion between absolute dense area and percentage dense
area and risk of breast cancer. We had no ap r i o r i
hypothesis regarding the association between nondense
mammographic area and risk of breast cancer.
Materials and methods
We conducted a nested case-control study on mammo-
graphic density and risk of breast cancer in the Nurses’
Health Study (NHS) and Nurses’ Health Study II (NHS
II).
The Nurses’ Health Study
The NHS started in 1976, when 121,700 US registered
nurses ages 30 to 55 years completed a questionnaire
about their medical history, reproductive history and
lifestyle habits [11]. Follow-up questionnaires have been
mailed to the participants every two years since
(response rate > 90% per questionnaire cycle). In 1989
and 1990, a total of 32,826 participants provided blood
samples.
In the current study, we made use of an existing
breast cancer case-control study nested within the sub-
cohort of women who provided a blood sample and had
no history of breast cancer at the time they provided
the sample. During follow-up to 1 June 2004, there were
1,897 incident cases of breast cancer reported on the
biennial questionnaire and confirmed by medical record
review. These cases were matched to 3,165 controls on
age, menopausal status, current use of postmenopausal
hormones, month, time of day and fasting status at the
time of blood collection. At the time of mammographic
data collection, 1,612 cases and 2,857 controls were
alive and were sent letters requesting their participation
in the study. We attempted to obtain mammograms
taken as close to the date of blood collection as possible
from 1,504 cases and 2,512 controls who gave their per-
mission to participate. We obtained mammograms from
1,446 cases and 2,406 controls. We excluded 37 cases
and 35 controls because of poor-quality mammograms,
104 cases whose date of mammogram was after the date
of the breast cancer diagnosis and 9 controls with dis-
crepant information regarding menopausal status at the
date of the mammogram and at the date of diagnosis/
index date. In total, we had usable mammograms for
1,305 cases and 2,362 controls. The median time
between mammography and blood draw was 11 months
before blood collection (IQR = 46 months). The median
time between mammography and breast cancer diagno-
sis was 4.6 years (IQR = 5.3 years).
The Nurses’ Health Study II
The NHS II started in 1989, when 116,686 US registered
nurses ages 25 to 42 years completed a questionnaire
about their medical history, reproductive history and
lifestyle habits [11]. Follow-up questionnaires have been
mailed to the participants every two years since
(response rate approximately 90% per questionnaire
cycle). From 1995 through 1999, a total of 29,611 parti-
cipants provided blood samples.
As in the NHS, our current study was nested within
the subcohort of women who had no history of breast
cancer at the time they provided a blood sample. During
follow-up to 1 June 2003, there were 318 incident cases
of breast cancer reported on the biennial questionnaire
and confirmed by medical record review. These cases
were matched to 635 controls on age, menopausal sta-
tus, current use of postmenopausal hormones, month,
time of day and fasting status at the time of blood col-
lection. At the time of mammographic data collection,
304 cases and 624 controls were alive and were sent let-
ters requesting their participation. We attempted to
obtain mammograms taken as close to the date of blood
collection as possible from 274 cases and 519 controls
who gave their permission to participate. We obtained
mammograms from 253 cases and 502 controls. We
excluded 13 cases and 15 controls because of poor-qual-
ity mammograms, 17 cases whose date of mammogram
was after the date of the breast cancer diagnosis, and 1
case and 5 controls with discrepant information regard-
ing menopausal status at the date of the mammogram
and at the date of diagnosis/index date. In total, we had
usable mammograms for 222 cases and 482 controls.
The median time between mammography and blood
draw was 3 months before blood collection (IQR = 18
months). The median time between mammography and
breast cancer diagnosis was 2.1 years (IQR = 2.6 years).
Mammographic density measurements
The detailed methods used for mammographic density
measurement in this study have been published pre-
viously [12]. Briefly, the craniocaudal views of both
breasts were digitized with a Lumisys 85 digital laser
film scanner (Lumisys, Sunnyvale, CA, USA). We used
Cumulus software (Canto Software Inc, San Francisco,
CA, USA) for computer-assisted thresholding to mea-
sure absolute dense area, absolute nondense area (the
total area minus the dense area) and percentage dense
area (the dense area divided by the total area). For each
batch of mammograms on which the observer measures
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were included as quality control samples to assess the
reliability of the reader. The observer was blinded to the
case-control and quality control status of the mammo-
grams. For each batch, the within-person intraclass cor-
relation coefficient has been at least 0.90. The average
density parameters of both breasts were used for this
analysis.
Covariate information
We used the most recent information from the two
biennial questionnaires preceding the date of the mam-
mogram to obtain data on the following covariates:
body mass index (BMI in kg/m
2), current postmenopau-
sal hormone use (PMH) and alcohol intake (g/day).
Thus information on BMI, PMH use and alcohol intake
was extracted from questionnaires returned by the parti-
cipants 0 to 4 years before mammography. For the cov-
ariates age at menarche, menopausal status, parity, age
at first childbirth, age at menopause and family history
of breast cancer, we used the most recent information
from any biennial questionnaire returned by the partici-
pant before the mammography.
Statistical analysis
We combined the cases and controls from NHS and
NHS II to increase the power of our study. We excluded
women with unknown menopausal status at the time of
mammogram (n = 287). After these exclusions, 464
cases and 998 controls with premenopausal mammo-
grams and 960 cases and 1,662 controls with postmeno-
pausal mammograms remained for analysis.
Among women with premenopausal mammograms,
we divided the mammographic density measurements
into tertiles based on the distribution among the con-
trols. Given the larger sample size of postmenopausal
women compared with premenopausal women, we were
able to examine finer categories of the distribution
among postmenopausal women. Among women with
postmenopausal mammograms, the mammographic
density measurements were divided into quintiles based
on the distribution among the controls. All covariates
except for alcohol consumption and PMH use had miss-
ing data for less than 2% of both cases and controls and
were assigned the reference category or median value.
Women with missing information on alcohol consump-
tion (n = 232) or PMH use (n =2 1 0 )w e r ea s s i g n e da
missing indicator variable. As a sensitivity analysis, we
restricted the analysis to women with no missing infor-
mation on any covariates (420 cases and 917 controls
with premenopausal mammograms and 806 cases and
1,432 controls with postmenopausal mammograms).
In the original nested case-control studies described
above, controls were matched to cases on age and on
other variables related to blood collection. For the cur-
rent study, because we were unable to obtain mammo-
grams for all eligible women, the original matching was
not maintained. Therefore, we used unconditional logis-
tic regression to calculate OR and 95% CI data and
adjusted all models for age at mammography (continu-
ous) and study (NHS or NHS II). The multivariate
model was additionally adjusted for the following cate-
gorical and continuous variables using data reported clo-
sest in time to the mammography: BMI (< 20, 20 to <
22.5, 22.5 to < 25, 25 to < 27.5, 27.5 to < 30, 30 to <
32.5, 32.5 to < 35 and ≥ 35), age at menarche (< 12, 12
to 13 and ≥ 14 years), family history of breast cancer
(yes or no), parity and age at first childbirth (nullipar-
ous, < 3 children by age < 26 years, < 3 children by age
≥ 26 years, ≥ 3c h i l d r e nb ya g e<2 6y e a r sa n d≥ 3 chil-
dren by age ≥ 26 years), alcohol use (0, < 5, 5 to < 15, ≥
15 g/day or unknown), and, for women who were post-
menopausal at the time of mammography, PMH use
(yes, no or unknown) and age at menopause (continu-
ous). We also adjusted for absolute dense area and abso-
lute nondense area simultaneously in the multivariate
model. We assessed the interaction between absolute
dense area and nondense area with respect to breast
cancer risk on the continuous scale. Absolute dense
area, absolute nondense area and the cross-product of
these factors were entered to the multivariate models as
continuous variables, and we used the Wald test to
assess the statistical significance of the interaction
terms. We also investigated, on the continuous scale,
whether there was an interaction between the different
measurements of mammographic density and BMI.
Since premenopausal and postmenopausal breast can-
cer may have, in part, different etiologies, and because
some women who were premenopausal at the time of
mammography were postmenopausal at the time of
breast cancer diagnosis, we conducted a sensitivity ana-
lysis in which we restricted that analysis to women who
were premenopausal at the time of mammography and
at the time of breast cancer diagnosis (263 cases and
586 controls). This study was approved by the Commit-
tee on the Use of Human Subjects in Research at Brig-
ham and Women’s Hospital. All participants in this
study provided informed consent.
Results
In this study, there were 464 breast cancer cases and
998 controls with premenopausal mammograms, as well
as 960 breast cancer cases and 1,662 controls with post-
menopausal mammograms. Among controls, premeno-
pausal women with higher absolute dense area were
younger at the time of mammography, were somewhat
older at the time of menarche, were more often nulli-
parous, were older when they had their first child, had
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higher absolute nondense area tended to be younger at
menarche, consumed less alcohol and had considerably
higher BMI. Trends across categories of percentage
d e n s ea r e aw e r el a r g e l ys i m i l a rt ot h o s ef o ra b s o l u t e
dense area, although women with higher percentage
dense area consumed more alcohol and had noticeably
lower BMI. A similar descriptive analysis among post-
menopausal controls is presented in Table 2. With
increasing absolute dense area, women had fewer chil-
dren, were somewhat older when they had their first
child and more often used PMH. With increasing abso-
lute nondense area, women had higher BMI, were
younger when they had their first child and at the time
of menopause, and consumed less alcohol. As among
premenopausal women, percentage dense area largely
reflected the results for absolute dense area. Notably,
women with higher percentage dense area were younger
Table 1 Age-adjusted (≤45, 46+ years) characteristics at premenopausal mammography among 998 control women
without breast cancer according to tertiles of absolute dense area, absolute non-dense area, and percent dense area
Tertiles of absolute dense area in cm
2
Characteristics 1 (< 42.5) 2 (< 79.3) 3 (< 300.1)
Number of controls 330 339 329
Age at mammography, years 48.7 47.3 45.8
Age at menarche, years 12.3 12.4 12.5
Family history of breast cancer, % 6.9 8.6 8.0
Nulliparous at the time of mammography, % 7.2 7.6 13.9
Number of children at mammography
1 2.7 2.6 2.4
Age at first birth, years
1 25.1 25.7 26.1
Body mass index at mammography, kg/m
2 26.6 24.7 24.7
Alcohol use at mammography, g/day 4.1 5.5 4.6
Total area on mammogram, cm
2 164 177 253
Absolute non-dense area on mammogram, cm
2 139 117 131
Tertiles of absolute non-dense area in cm
2
Characteristics 1 (< 69.5) 2 (< 145.1) 3 (< 482.6)
Number of controls 330 339 329
Age at mammography, years 47.3 47.4 47.2
Age at menarche, years 12.5 12.5 12.2
Family history of breast cancer, % 6.6 8.6 7.3
Nulliparous at the time of mammography, % 11.7 8.3 8.8
Number of children at mammography
1 2.5 2.6 2.6
Age at first birth, years
1 25.6 25.8 25.5
Body mass index at mammography, kg/m
2 22.4 24.6 28.7
Alcohol use at mammography, g/day 5.8 4.7 3.9
Total area on mammogram, cm
2 105 181 304
Absolute dense area on mammogram, cm
2 62 76 70
Tertiles of percent dense area
Characteristics 1 (< 27.8) 2 (< 49.9) 3 (< 90.4)
Number of controls 330 339 329
Age at mammography, years 48.2 47.4 46.4
Age at menarche, years 12.1 12.5 12.6
Family history of breast cancer, % 6.5 9.2 7.2
Nulliparous at the time of mammography, % 7.1 9.3 12.5
Number of children at mammography
1 2.8 2.6 2.4
Age at first birth, years
1 25.0 26.2 25.7
Body mass index at mammography, kg/m
2 28.5 24.5 22.7
Alcohol use at mammography, g/day 4.1 4.9 5.5
Total area on mammogram, cm
2 238 194 156
Absolute dense area on mammogram, cm
2 35 75 96
Absolute non-dense area on mammogram, cm
2 203 119 59
1) Among parous women.
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control women without breast cancer according to quintiles of absolute dense area, absolute non-dense area, and
percent dense area
Quintiles of absolute dense area in cm
2
Characteristics 1 (< 14.4) 2 (< 26.6) 3 (< 39.8) 4 (< 64.3) 5 (< 302.6)
Number of controls 333 332 333 332 332
Age at mammography, years 62.2 61.4 62.0 60.6 60.4
Age at menopause, years 49.2 49.5 49.8 49.0 49.0
Age at menarche, years 12.6 12.7 12.6 12.6 12.6
Family history of breast cancer, % 11.6 12.0 14.0 13.0 13.2
Nulliparous at the time of mammography, % 4.0 5.5 5.2 8.0 10.2
Number of children at mammography
1 3.6 3.6 3.4 3.2 3.2
Age at first child, years
1 25.1 25.1 25.2 25.4 25.4
Body mass index at mammography, kg/m
2 28.2 26.2 25.4 25.1 25.5
Alcohol use at mammography, g/day 5.9 5.7 4.7 5.9 4.9
Current hormonal use, % 30.3 34.6 34.8 42.4 56.1
Total area on mammogram, cm
2 169 169 182 216 268
Absolute non-dense area on mammogram, cm
2 162 148 149 164 171
Quintiles of absolute non-dense area in cm
2
Characteristics 1 (< 76.2) 2 (< 115.6) 3 (< 163.9) 4 (< 231.4) 5 (< 538.8)
Number of controls 333 332 333 332 332
Age at mammography, years 60.7 60.4 61.6 62.1 61.9
Age at menopause, years 49.6 49.5 49.2 49.2 48.9
Age at menarche, years 12.8 12.6 12.6 12.5 12.4
Family history of breast cancer, % 12.1 14.2 11.8 13.0 12.6
Nulliparous at the time of mammography, % 8.3 8.4 5.3 5.1 6.4
Number of children at mammography
1 3.4 3.5 3.4 3.4 3.3
Age at first child, years
1 25.5 25.4 25.2 25.2 24.9
Body mass index at mammography, kg/m
2 22.4 24.7 25.9 27.5 30.1
Alcohol use at mammography, g/day 6.9 6.0 5.6 5.2 3.2
Current hormonal use, % 47.6 39.9 33.8 38.6 36.1
Total area on mammogram, cm
2 93 135 179 241 355
Absolute dense area on mammogram, cm
2 41 39 40 45 46
Quintiles of percent dense area
Characteristics 1 (< 8.1) 2 (< 15.7) 3 (< 24.1) 4 (< 37.1) 5 (< 86.5)
Number of controls 334 331 333 332 332
Age at mammography, years 62.2 62.0 61.8 60.8 59.7
Age at menopause, years 49.1 49.7 49.3 49.1 49.0
Age at menarche, years 12.6 12.5 12.5 12.7 12.8
Family history of breast cancer, % 10.7 14.3 12.0 12.8 13.9
Nulliparous at the time of mammography, % 6.2 2.7 5.5 8.0 11.4
Number of children at mammography
1 3.6 3.5 3.4 3.2 3.1
Age at first child, years
1 25.2 24.8 25.1 25.4 25.8
Body mass index at mammography, kg/m
2 29.9 26.9 25.7 24.4 23.4
Alcohol use at mammography, g/day 5.2 4.3 5.4 6.0 6.1
Current hormonal use, % 27.1 32.7 36.4 47.3 54.1
Total area on mammogram, cm
2 231 223 210 182 154
Absolute dense area on mammogram, cm
2 10 27 41 55 76
Non-dense breast area on mammogram, cm
2 221 196 169 127 78
1) Among parous women.
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PMH. The correlations between absolute dense and
nondense areas were 0.03 in premenopausal women and
0.03 in postmenopausal women.
Increasing absolute dense area was associated with a
greater risk of breast cancer after we adjusted for poten-
tial confounding factors among premenopausal women
(ORtertile 3 vs 1 = 2.01, 95% CI = 1.45 to 2.77) and post-
menopausal women (ORquintile 5 vs 1 = 2.19; 95% CI =
1.65 to 2.89) (Tables 3 and 4). In contrast, increasing
absolute nondense area was associated with a decreased
risk of breast cancer among premenopausal women
(ORtertile 3 vs 1 = 0.51, 95% CI = 0.36 to 0.72) and post-
menopausal women (ORquintile 5 vs 1 = 0.46; 95% CI =
0.34 to 0.62). When we additionally mutually adjusted
for absolute dense area and absolute nondense area, the
results were generally similar. Among both pre- and
postmenopausal women, the percentage dense area was
most strongly associated with breast cancer. We found
no significant interactions between absolute dense area,
absolute nondense area, or percentage dense area and
BMI among premenopausal or postmenopausal women
(all P-values > 0.05).
Table 5 and 6 show risk estimates for breast cancer by
cross-classified categories of absolute dense area and
absolute nondense area. In both pre- and postmenopau-
sal women, the risk of breast cancer increased with
higher absolute dense area within each category of abso-
lute nondense area, and, conversely, the risk decreased
with higher absolute nondense area within each category
of absolute dense area (P =0 . 2 6f o ri n t e r a c t i o nf o rp r e -
menopausal mammographic measurements, and P =
0.97 for interaction for postmenopausal mammographic
measurements).
In a sensitivity analysis restricted to women who were
premenopausal both at the time of mammography and
at the time of breast cancer diagnosis, the results were
generally similar (Additional file 1, Table S1). Also,
results from the sensitivity analysis restricted to cases
and controls with information on all covariates were
quantitatively similar to the results from the primary
analysis (data not shown).
Discussion
We found that higher absolute dense area on a mam-
mogram was associated with an increased risk of breast
cancer, whereas higher absolute nondense area was
associated with a decreased risk. When we adjusted for
both of these factors simultaneously, the associations
remained. Our results suggest that absolute dense area
is independently and positively associated with breast
cancer risk, whereas absolute nondense area is indepen-
dently and inversely associated with breast cancer risk.
Two previous studies have reported the association
between absolute nondense area and the risk of breast
cancer. The UK Guernsey prospective studies (111 cases
of breast cancer) found that women in the highest ver-
s u sl o w e s tq u a r t i l eo fa b s o l u t en o n d e n s ea r e ah a da
hazard ratio of 0.56 (95% CI = 0.29 to 1.11; P for trend
= 0.18) for breast cancer, but reported no risk estimates
for absolute nondense area adjusted for absolute dense
area [7]. Stone and colleagues [6], in a case-control
study of 634 cases and 1,880 controls, found that
women in the highest versus lowest quintile of absolute
Table 3 Odds ratios for breast cancer according to tertiles of different premenopausal mammographic characteristics
among 464 cases and 998 controls
Odds Ratios and 95% Confidence Intervals
Mammographic characteristics Cases Controls Model 1
1 Model 2
2 Model 3
3
Absolute dense area, tertiles
1 113 330 1.00 1.00 1.00
2 156 339 1.43 (1.07-1.92) 1.40 (1.04-1.88) 1.39 (1.03-1.87)
3 195 329 2.07 (1.52-2.84) 2.01 (1.45-2.77) 2.05 (1.48-2.84)
Absolute non-dense area, tertiles
1 192 330 1.00 1.00 1.00
2 153 339 0.77 (0.59-1.01) 0.72 (0.54-0.95) 0.69 (0.52-0.92)
3 119 329 0.62 (0.47-0.83) 0.51 (0.36-0.72) 0.50 (0.35-0.71)
Percent dense area, tertiles
1 95 330 1.00 1.00 N/A
2 167 339 1.75 (1.30-2.36) 1.95 (1.41-2.69)
3 202 329 2.18 (1.62-2.92) 2.72 (1.93-3.83)
1) Adjusted for age at mammography (continuous), study (Nurses’ Health Study, Nurses’ Health Study II).
2) Adjusted for age at mammography (continuous), study (Nurses’ Health Study, Nurses’ Health Study II), age at menarche (< 12, 12-13, ≥ 14), family history of
breast cancer (yes, no), parity + age at first birth (nulliparous, < 3 children age < 26, < 3 children age ≥ 26, ≥ 3 children age < 26, ≥ 3 children age ≥ 26), body
mass index (< 20, 20-< 22.5, 22.5-< 25, 25-< 27.5, 27.5-< 30, 30-< 32.5, 32.5-< 35, ≥ 35 kg/m
2), and alcohol use (0, < 5, 5-< 15, ≥ 15 g/day, unknown).
3) Adjusted for covariates in model 2, plus absolute non-dense or absolute dense area (tertiles), as appropriate.
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1.08; P for trend = 0.02) for breast cancer. After adjust-
ment for absolute dense area, the OR changed to 1.08
(95% CI = 0.79 to 1.49; P for trend = 0.7). Although
both of these studies suggest an inverse association
between nondense area and breast cancer risk, it is
unclear why adjustment for dense area in the Stone et
al. study had a different effect than in the current study.
Both studies used the same computer-assisted thresh-
olding techniques to measure mammographic density;
however, Stone and colleagues used the mediolateral
oblique mammogram view, whereas we used the cranio-
caudal view. Although the mammogram view may affect
the mammographic density measurements and thus
their ability to predict breast cancer risk, it seems unli-
kely to explain our different study findings [6,13]. Taken
together, the unexplained differences in study findings
underscore the importance of investigating the associa-
tion between the nondense area on a mammogram and
the risk of breast cancer in additional independent
cohorts.
Prior findings published by Stuedal and colleagues [14]
lend indirect to support to the notion that nondense
mammographic area is inversely associated with breast
cancer risk. Stuedal and colleagues examined if the asso-
ciation between mammographic density and breast can-
cer risk differs according to the size of the breasts. They
used the total breast area on a mammogram as a proxy
for breast size and found that the association between
absolute dense area and breast cancer risk was signifi-
cantly lower in larger breasts [14]. For percentage dense
Table 5 Multivariate
1 odds ratios (ORs) and 95%
Confidence Intervals (CIs) for breast cancer by tertiles of
absolute dense area and absolute non-dense area on a
premenopausal mammogram
Tertiles non-dense area
1
OR (95% CI)
2
OR (95% CI)
3
OR (95% CI)
Tertiles dense area
1 2.40 (1.30-4.46) 2.13 (1.15-3.93) 1.00
cases/controls 51/122 38/91 24/117
2 3.44 (1.91-6.18) 2.28 (1.26-4.14) 1.76 (0.96-3.22)
cases/controls 76/131 46/111 34/97
3 5.10 (2.78-9.37) 3.16 (1.78-5.63) 2.78 (1.57-4.92)
cases/controls 65/77 69/137 61/115
P interaction = 0.26
1) Adjusted for age at mammography (continuous), study (Nurses’ Health
Study, Nurses’ Health Study II), age at menarche (< 12, 12-13, ≥ 14), family
history of breast cancer (yes, no), parity + age at first birth (nulliparous, < 3
children age < 26, < 3 children age ≥ 26, ≥ 3 children age < 26, ≥ 3 children
age ≥ 26), body mass index (< 20, 20-< 22.5, 22.5-< 25, 25-< 27.5, 27.5-< 30,
30-< 32.5, 32.5-< 35, ≥ 35 kg/m
2), and alcohol use (0, < 5, 5-< 15, ≥ 15 g/day,
unknown).
Table 4 Odds ratios for breast cancer according to quintiles of different postmenopausal mammographic
characteristics among 960 cases and 1,662 controls
Odds Ratios and 95% Confidence Intervals
Mammographic characteristics Cases Controls Model 1
1 Model 2
2 Model 3
3
Absolute dense area, quintiles
1 117 333 1.00 1.00 1.00
2 167 332 1.42 (1.08-1.89) 1.44 (1.08-1.92) 1.39 (1.04-1.86)
3 167 333 1.43 (1.08-1.89) 1.44 (1.08-1.92) 1.42 (1.06-1.90)
4 240 332 2.07 (1.58-2.71) 1.99 (1.50-2.62) 2.04 (1.53-2.70)
5 269 332 2.40 (1.83-3.13) 2.19 (1.65-2.89) 2.30 (1.74-3.06)
Absolute non-dense area, quintiles
1 271 333 1.00 1.00 1.00
2 177 332 0.66 (0.52-0.84) 0.60 (0.47-0.78) 0.62 (0.47-0.80)
3 186 333 0.70 (0.55-0.89) 0.63 (0.48-0.82) 0.62 (0.48-0.82)
4 178 332 0.68 (0.53-0.86) 0.58 (0.44-0.76) 0.55 (0.41-0.72)
5 148 332 0.56 (0.44-0.73) 0.46 (0.34-0.62) 0.41 (0.30-0.56)
Percent dense area, quintiles
1 109 334 1.00 1.00 N/A
2 161 331 1.49 (1.12-1.98) 1.56 (1.16-2.10)
3 153 333 1.42 (1.06-1.89) 1.57 (1.16-2.13)
4 231 332 2.13 (1.62-2.81) 2.44 (1.81-3.30)
5 306 332 2.83 (2.17-3.71) 3.28 (2.41-4.45)
1) Adjusted for age at mammography (continuous), study (Nurses’ Health Study, Nurses’ Health Study II).
2) Adjusted for age at mammography (continuous), study (Nurses’ Health Study, Nurses’ Health Study II), age at menarche (< 12, 12-13, ≥ 14), family history of
breast cancer (yes, no), parity + age at first birth (nulliparous, < 3 children age < 26, < 3 children age ≥ 26, ≥ 3 children age < 26, ≥ 3 children age ≥ 26), body
mass index (< 20, 20-< 22.5, 22.5-< 25, 25-< 27.5, 27.5-< 30, 30-< 32.5, 32.5-< 35, ≥ 35 kg/m
2), alcohol use (0, < 5, 5-< 15, ≥ 15 g/day, unknown), age at
menopause (continuous), and current hormonal therapy (yes, no, unknown).
3) Adjusted for covariates in model 2, plus absolute non-dense or absolute dense area (quintiles), as appropriate.
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significant. Their results suggest that absolute dense
area, and possibly percentage dense area, is a weaker
predictor of breast cancer risk in larger breasts. Stuedal
and colleagues put forth several possible explanations
for their findings, including measurement error, a higher
proportion of dense tissue in the largest breasts may be
less correlated with the number of epithelial cells at
risk, and fat in the breast having a potential protective
effect on breast cancer risk.
Previous research has led to the hypotheses that mam-
mographic density reflects the proliferation of epithelial
and stromal cells [15,16], the number of mammary stem
cells at risk of developing breast cancer [10] and/or the
cumulative exposure of the breast to different mitogens
and mutagens [16]. If these hypotheses are correct,
absolute dense volume should be a better predictor of
breast cancer risk than percentage dense area or percen-
tage dense volume. Boyd and colleagues used two differ-
ent novel techniques to estimate absolute and
percentage dense volume on the basis of mammograms
[3,17]. In these studies, absolute dense volume was not
found to be a stronger risk factor for breast cancer than
percentage dense area or volume, suggesting that per-
centage dense area or volume contains information
about breast cancer risk that goes beyond the total
amount of epithelium and stroma in the breasts.
Several different factors or mechanisms can explain
the inverse association between absolute nondense area
and breast cancer risk that we found. Absolute non-
d e n s ea r e am a yb eam a r k e ro fs o m eo t h e rf a c t o r st h a t
in turn are true protective factors for both premeno-
pausal and postmenopausal breast cancer. Although
BMI is the strongest confounder of this association,
adjusting for BMI did not explain but a small fraction
of the association. In addition, we controlled for sev-
eral other potential confounding factors, and adjusting
for these factors did not materially alter the results,
although some residual confounding cannot be
excluded.
Our results support the view that breast fat could have
a protective effect on breast cancer risk [14]. Little is
known about the role of breast adipose tissue in breast
carcinogenesis. On the basis of previous literature, how-
ever, it appears more likely that higher amounts of adi-
pose breast tissue would increase rather than decrease
the risk of breast cancer [18]. Adipose tissue is an
important source of estrogens, and higher levels of
estrogens, especially locally, would presumably increase
breast cancer development and progression. In addition,
increased adiposity is associated with increased levels of
potentially cancer-promoting adipokines, such as leptin,
and decreased levels of potential anticancer adipokines,
such as adiponectin [19]. A possible explanation of our
findings, in addition to adipose tissue having a potential
protective effect per se, is that the dense area and the
nondense area on a mammogram reflect the extent of
conversion of the breast tissue into either dense tissue
that is associated with breast cancer risk or nondense
tissue that is not. Lobular involution is inversely asso-
ciated with breast cancer risk. Ghosh and colleagues
[20] reported an inverse association between involution
and percentage dense area; specifically, they found no
association between involution and absolute dense area,
but a positive association between involution and abso-
lute nondense area.
Table 6 Multivariate
1 odds ratios (ORs) and 95% Confidence Intervals (CIs) for breast cancer by quintiles of absolute
dense area and absolute non-dense area on a postmenopausal mammogram
Quintiles non-dense area
1
OR (95% CI)
2
OR (95% CI)
3
OR (95% CI)
4
OR (95% CI)
5
OR (95% CI)
Quintiles dense area
1 2.92 (1.23-6.93) 1.39 (0.66-2.90) 1.73 (0.86-3.50) 1.04 (0.50-2.16) 1.00
cases/controls 16/29 26/80 35/85 24/83 16/56
2 3.75 (1.89-7.45) 1.98 (0.94-4.17) 1.58 (0.76-3.29) 2.05 (0.95-4.43) 1.42 (0.68-2.96)
cases/controls 65/91 27/62 27/74 23/43 25/62
3 3.68 (1.84-7.36) 1.84 (0.89-3.79) 1.58 (0.73-3.42) 2.05 (0.99-4.25) 1.73 (0.83-3.62)
cases/controls 59/82 31/77 21/56 30/62 26/56
4 4.82 (2.44-9.53) 3.30 (1.60-6.80) 3.01 (1.46-6.20) 2.91 (1.45-5.85) 1.80 (0.90-3.60)
cases/controls 80/76 41/53 37/55 44/65 38/83
5 4.29 (2.10-8.76) 3.83 (1.90-7.75) 4.36 (2.20-8.64) 2.88 (1.46-5.66) 2.15 (1.08-4.26)
cases/controls 51/55 52/60 66/63 57/79 43/75
P interaction = 0.97
1) Adjusted for age at mammography (continuous), study (Nurses’ Health Study, Nurses’ Health Study II), age at menarche (< 12, 12-13, ≥ 14), family history of
breast cancer (yes, no), parity + age at first birth (nulliparous, < 3 children age < 26, < 3 children age ≥ 26, ≥ 3 children age < 26, ≥ 3 children age ≥ 26), body
mass index (< 20, 20-< 22.5, 22.5-< 25, 25-< 27.5, 27.5-< 30, 30-< 32.5, 32.5-< 35, ≥ 35 kg/m
2), alcohol use (0, < 5, 5-< 15, ≥ 15 g/day, unknown), age at
menopause (continuous), and current hormonal therapy (yes, no, unknown).
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Page 8 of 10A limitation of this study is that we were unable to
collect mammograms from all eligible women. How-
ever, we have no reason to suspect that women with
missing mammograms are systematically different from
women for whom we were able to collect mammo-
grams. In addition, our findings regarding absolute
dense area and percentage dense area in relation to
breast cancer risk are in line with those of numerous
previous studies, indicating that our measurements of
mammographic density, including absolute nondense
area, are valid. Another limitation of this study is that
information on some covariates that can change sub-
stantially over a short period of time, notably BMI,
PMH use and alcohol consumption, was retrieved from
questionnaires returned by the participants up to four
years before mammography. This could have led to
misclassification of the covariates and thus to residual
confounding.
Conclusions
Our results indicate that absolute dense area is indepen-
dently and positively associated with breast cancer risk,
whereas absolute nondense area is independently and
inversely associated with breast cancer risk. We propose
that the nondense area on a mammogram should be
investigated as a distinct factor when studying the asso-
ciation between mammographic patterns and risk of
breast cancer. Furthermore, our results suggest that adi-
pose breast tissue may have an important protective role
in breast carcinogenesis.
Additional material
Additional file 1: Table S1: Odds ratios for breast cancer among
women who were premenopausal at the time of mammography
and at the time of breast cancer diagnosis according to tertiles of
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